| Q39527265 | Advances in drug development for acute migraine |
| Q38175134 | Calcium-permeable ion channels in pain signaling |
| Q89545828 | Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell |
| Q41232330 | Cobra neurotoxin produces central analgesic and hyperalgesic actions via adenosine A1 and A2A receptors |
| Q35669940 | Compound MQA, a Caffeoylquinic Acid Derivative, Protects Against NMDA-Induced Neurotoxicity and Potential Mechanisms In Vitro. |
| Q53443172 | Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice. |
| Q38727831 | Current and Future Issues in the Development of Spinal Agents for the Management of Pain |
| Q48227909 | Different effects of dexmedetomidine and midazolam on the expression of NR2B and GABAA-α1 following peripheral nerve injury in rats |
| Q35656080 | Estradiol modulates visceral hyperalgesia by increasing thoracolumbar spinal GluN2B subunit activity in female rats |
| Q47131605 | Experimental Gene Therapy with Serine-Histogranin and Endomorphin 1 for the Treatment of Chronic Neuropathic Pain. |
| Q41868656 | GluN2B N-methyl-D-aspartate receptor and excitatory amino acid transporter 3 are upregulated in primary sensory neurons after 7 days of morphine administration in rats: implication for opiate-induced hyperalgesia |
| Q34061815 | Increased sensitivity to inflammatory pain induced by subcutaneous formalin injection in serine racemase knock-out mice |
| Q55003481 | Inhibition of Connexin 43 and Phosphorylated NR2B in Spinal Astrocytes Attenuates Bone Cancer Pain in Mice. |
| Q37343075 | Involvement of Brain-Enriched Guanylate Kinase-Associated Protein (BEGAIN) in Chronic Pain after Peripheral Nerve Injury. |
| Q64993792 | Loss of STEP61 couples disinhibition to N-methyl-d-aspartate receptor potentiation in rodent and human spinal pain processing. |
| Q44349884 | Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord |
| Q34445139 | N-methyl-D-aspartate receptor antagonist MK-801 prevents apoptosis in rats that have undergone fetal spinal cord transplantation following spinal hemisection |
| Q55514073 | NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation. |
| Q38090368 | Opioid administration following spinal cord injury: implications for pain and locomotor recovery |
| Q37632659 | Probing NMDA receptor GluN2A and GluN2B subunit expression and distribution in cortical neurons |
| Q90665026 | Propofol attenuates postoperative hyperalgesia via regulating spinal GluN2B-p38MAPK/EPAC1 pathway in an animal model of postoperative pain |
| Q41898511 | Role of Fyn-mediated NMDA receptor function in prediabetic neuropathy in mice |
| Q54442662 | Spinal serum-inducible and glucocorticoid-inducible kinase 1 mediates neuropathic pain via kalirin and downstream PSD-95-dependent NR2B phosphorylation in rats. |
| Q37678477 | Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain |
| Q42689188 | [EXPRESS] Propofol produces preventive analgesia via GluN2B-containing NMDA Receptor/ERK1/2 Signaling Pathway in a rat model of inflammatory pain. |
| Q38051429 | siRNA: a new approach to target neuropathic pain |